News archive

Improved FAP-radiotheranostics for personalized cancer treatment

Improved FAP-radiotheranostics for personalized cancer treatment Cancer-associated fibroblasts (CAFs) are a group of tumor stromal cells typically associated with cancer growth and metastasis. These CAFs show high expression of the fibroblast activation protein (FAP) on the cell membrane. Due to the selective FAP expression and cancer-specific distribution, CAFs have emerged as a promising cancer diagnostic marker and an attractive therapeutic target.

READ MORE

European Molecular Imaging Meeting (EMIM) 2023 Award

Louis Lauwerys a PhD student from CREANT has won a poster award at the European Molecular Imaging Meeting (EMIM) in Salzburg (Austria) for his work on the design and evaluation of a novel caspase-3 radiotracer for monitoring apoptosis in response to cancer therapy. Congratulations Louis!

READ MORE

PhD defence Jonatan Dewulf

On November 3, 2022, Jonatan Dewulf, a member of CREANT, has defended his PhD thesis entitled: ‘Elucidating the tumor microenvironment: immuno-PET imaging of RANKL and CD70’ Congratulations Jonatan!

READ MORE

Publication

Our team has developed a novel immuno-PET imaging tool that can help tailoring cancer therapies. Check out our latest publication.

READ MORE

PRISMAP

The European medical isotope programme – PRISMAP – has launched. This consortium aims to fast-track nuclear medicine research. Check the website!

READ MORE

Welcome!

The website for the Center for Radiopharmaceuticals Antwerp (CREANT) was just launched. More news coming soon.

READ MORE